Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne Collins

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of the National Medical Association|December 16, 2005
Long-term pegylated liposomal doxorubicin use in recurrent ovarian carcinomaYvonne Collins, Shashikant Lele
Journal of Lower Genital Tract Disease|October 6, 2005
Risk of high-grade cervical intraepithelial neoplasia among young women with abnormal screening cytologyStewart L Massad, Stephen Markwell, Helen E Cejtin, et al.
Trends in Endocrinology and Metabolism: TEM|July 27, 2012
Mitochondrial oxidative stress and the metabolic syndromeAndrew M James, Yvonne Collins, Angela Logan, et al.
Gynecologic Oncology|March 23, 2010
Overcoming the barriers to HPV vaccination in high-risk populations in the USLevi S Downs, Isabel Scarinci, Mark H Einstein, et al.
Gynecologic Oncology|January 11, 2014
Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic OncologyYvonne Collins, Kevin Holcomb, Eloise Chapman-Davis, et al.
Gynecologic Oncology|February 10, 2004
Primary primitive neuroectodermal tumor of the uterus: a report of two cases and review of the literatureKunle Odunsi, Moshood Olatinwo, Yvonne Collins, et al.
Journal of Cell Science|March 27, 2012
Mitochondrial redox signalling at a glanceYvonne Collins, Edward T Chouchani, Andrew M James, et al.
Oncology Reports|January 14, 2004
Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated moleculesAli Ghadersohi, Kunle Odunsi, Shashikant Lele, et al.
Gynecologic Oncology|July 26, 2018
Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyRobert A Burger, Wei Deng, Vicky Makker, et al.
Gynecologic Oncology|September 19, 2006
Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists, Yvonne Collins, Mark H Einstein, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of the National Medical Association|December 16, 2005
Long-term pegylated liposomal doxorubicin use in recurrent ovarian carcinomaYvonne Collins, Shashikant Lele
Journal of Lower Genital Tract Disease|October 6, 2005
Risk of high-grade cervical intraepithelial neoplasia among young women with abnormal screening cytologyStewart L Massad, Stephen Markwell, Helen E Cejtin, et al.
Trends in Endocrinology and Metabolism: TEM|July 27, 2012
Mitochondrial oxidative stress and the metabolic syndromeAndrew M James, Yvonne Collins, Angela Logan, et al.
Gynecologic Oncology|March 23, 2010
Overcoming the barriers to HPV vaccination in high-risk populations in the USLevi S Downs, Isabel Scarinci, Mark H Einstein, et al.
Gynecologic Oncology|January 11, 2014
Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic OncologyYvonne Collins, Kevin Holcomb, Eloise Chapman-Davis, et al.
Gynecologic Oncology|February 10, 2004
Primary primitive neuroectodermal tumor of the uterus: a report of two cases and review of the literatureKunle Odunsi, Moshood Olatinwo, Yvonne Collins, et al.
Journal of Cell Science|March 27, 2012
Mitochondrial redox signalling at a glanceYvonne Collins, Edward T Chouchani, Andrew M James, et al.
Oncology Reports|January 14, 2004
Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated moleculesAli Ghadersohi, Kunle Odunsi, Shashikant Lele, et al.
Gynecologic Oncology|July 26, 2018
Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyRobert A Burger, Wei Deng, Vicky Makker, et al.
Gynecologic Oncology|September 19, 2006
Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists, Yvonne Collins, Mark H Einstein, et al.
Pageof 2